Abstract
The treatment of chronic wounds and other damaged tissues and organs remains a difficult task, in spite of greater adherence to recognised standards of care and a better understanding of pathophysiologic principles. Adipose derived stem cells (ADSCs), with their proliferative and impressive differentiation potential, may be used in the future in autologous cell therapy or grafting to replace damaged tissues. At this point in time, transplanted tissues are often rejected by the body. Autologous grafting would eliminate this problem. ADSCs are able to differentiate into a number of cells in vitro, for example smooth muscle cells (SMCs), when treated with lineage specific factors. SMCs play a key role in physiology and pathology as they form the principle layer of all SMC tissues. Smooth muscle biopsies are often impractical and morbid, and often lead to a low cell harvest. It has also been shown that SMCs derived from a diseased organ can lead to abnormal cells. Therefore, there is a great need for alternative sources of healthy SMCs. The use of ADSCs for cell-based tissue engineering (TE) represents a promising alternative for smooth muscle repair. This review discusses the potential uses of ADSCs and SMCs in regenerative medicine, and the potential of ADSCs to be differentiated into functional SMCs for TE and regenerative cellular therapies to repair diseased organs.
Similar content being viewed by others
Abbreviations
- ADSCs:
-
Adipose derived stem cells
- BAT:
-
Brown adipose tissue
- BDNF:
-
Brain derived neurotrophic factor
- BMSCs:
-
Bone marrow stem cells
- BM-SMPC:
-
Bone marrow-derived smooth muscle progenitor cells
- CBFA-1:
-
Core binding factor alpha subunit 1
- CNS:
-
Central nervous system
- DMD:
-
Duchenne muscular dystrophy
- ECM:
-
Extracellular matrix
- FM:
-
Fusion media
- GFAP:
-
Glial Fibrillary Acidic Protein
- GFP:
-
Green fluorescent protein
- hADSCs:
-
Human ADSCs
- HIBS:
-
Hardening injectable bone substitute
- ICH:
-
Intracerebral haemorrhage
- IL-5:
-
Interleukin-5
- MAP2:
-
Microtubule-associated protein 2
- MCAo:
-
Middle cerebral artery occlusion
- MHC:
-
Myosin heavy chain
- MyoD:
-
Myogenic determination
- OECs:
-
Olfactory ensheathing cells
- PLA:
-
Processed lipoaspirate
- PDGF BB:
-
Platelet-derived growth factor BB
- RT-PCR:
-
Reverse Transcriptase polymerase chain reaction
- SIS:
-
Small intestine submucosa
- SMCs:
-
Smooth muscle cells
- SMα-actin:
-
Smooth muscle α-actin
- SMIM:
-
Smooth muscle induction medium
- SM-MHC:
-
Smooth muscle myosin heavy chain
- SVF:
-
Stromal vascular fraction
- TE:
-
Tissue engineering
- TGF β1:
-
Transforming growth factor beta 1
References
Gimble, J. M., Katz, A. J., & Bunnell, B. A. (2007). Adipose-derived stem cells for regenerative medicine. Circulation Research, 100, 1249–1260.
Sandor, G. K. B., & Suuronen, R. (2008). Combining adipose-derived stem cells, resorbable scaffolds and growth factors: an overview of tissue engineering. JCDA, 74(2), 167–170.
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Furtell, J. W., Katz, A. J., et al. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering, 7(2), 211–228.
Kim, J. M., Lee, S., Chu, K., Jung, K., Song, E., Kim, S., et al. (2007). Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Research, 1183, 43–50.
Strem, B. M., Hicok, K. C., Zhu, M., Wulur, I., Alfonso, Z., Schreiber, R. E., et al. (2005). Multipotential differentiation of adipose tissue-derived stem cells. Keio Journal of Medicine, 54(3), 132–141.
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., et al. (2002). Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell, 13, 4279–4295.
Ogawa, R. (2006). The importance of adipose-derived stem cells and vascularised tissue regeneration in the field of tissue transplantation. Current Stem Cell Research and Therapy, 1, 13–20.
Fraser, J. K., Wulur, I., Alfonso, Z., & Hedrick, M. H. (2006). Fat tissue: an underappreciated source of stem cells for biotechnology. TRENDS in Biotechnology, 24(4), 150–154.
Schäffler, A., & Büchler, C. (2008). Concise review: adipose tissue-derived stromal cells—basic and clinical implications for novel cell-based therapies. Stem Cells, 25, 818–827.
Rodriguez, L. V., Alfonso, Z., Zhang, R., Leung, J., Wu, B., & Ignarro, L. J. (2006). Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proceeding of the National Academy of Sciences, 103(32), 12167–12172.
Wong, J. Z., Woodcock-Mitchell, J., Mitchell, J., Rippetoe, P., White, S., Absher, M., et al. (1998). Smooth muscle actin and myosin expression in cultured airway smooth muscle cells. AJP-Lung Cellular & Molecular Physiology, 274, 786–792.
Kang, S. K., Lee, D. H., Bae, Y. C., Kim, H. K., Baik, S. Y., & Jung, J. S. (2003). Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Experimental Neurology, 183, 355–366.
Wang, B., Han, J., Gao, Y., Xiao, Z., Chen, B., Wang, X., et al. (2007). The differentiation of rat adipose-derived stem cells into OEC-like cells on collagen scaffolds by co-culturing with OECs. Neuroscience Letters, 421, 191–196.
Wu, K., Liu, Y. L., Cui, B., & Han, Z. (2006). Application of stem cells for cardiovascular grafts tissue engineering. Transplant Immunology, 16, 1–7.
Bai, X., Pinkernell, K., Song, Y., Nabzdyk, C., Reisser, J., & Alt, E. (2006). Genetically selected stem cells from human adipose tissue express cardiac markers. Biochemical and Biophysical Research Communications, 353, 665–671.
Sanz-Ruiz, R., Fernandez Santos, M. E., Dominguez Munoa, M., Ludwig Martin, I., Parma, R., Sanchez Fernandez, P. L., et al. (2008). Adipose tissue-derived stem cells: the friendly side of a classic cardiovascular foe. Journal of Cardiovascular Translational Research, 1(1), 55–63.
Yamada, Y., Wang, X., Yokayama, S., Fukuda, N., & Takakura, N. (2006). Cardiac progenitor cells in brown adipose tissue repaired damaged myocardium. Biochemical and Biophysical Research Communications, 342, 662–670.
Valina, C., Pinkernell, K., Song, Y., Bai, X., Sadat, S., Campeau, R. J., et al. (2007). Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. European Heart Journal, 28, 2667–2677.
Elabd, C., Chiellini, C., Massoudi, A., Cochet, O., Zaragosi, L., Trojani, C., et al. (2007). Human adipose tissue-derived multipotent stem cells differentiate in vitro and in vivo into osteocyte-like cells. Biochemical and Biophysical Research Communications, 361, 342–348.
Vieira, N. M., Brandalise, V., Zucconi, E., Jazedje, T., Secco, M., Nunes, V. A., et al. (2008). Human multipotent adipose derived stem cells restore dystrophin expression of Duchenne skeletal muscle cells in vitro. Biology of the Cell, 100(4), 231–241.
Webb, R. C. (2003). Smooth muscle contraction and relaxation. Advances in Physiology Education, 27(4), 201–206.
van Eys, G. J. J. M., Voller, M. C. W., Timmer, E. D. J., Wehrens, X. H. T., Small, J. V., Schalken, J. A., et al. (1997). Smoothelin expression characteristics development of a smooth muscle cell in vitro system and identification of a vascular varient. Cell Structure and Function, 22, 65–72.
Suzuki, T., Nagai, R., & Yazaki, Y. (1998). Mechanisms of transcriptional regulation of gene expression in smooth muscle cells. Circulation Research, 82, 1238–1242.
Halayko, A. J., Camoretti-Mercado, B., Forsythe, S. M., Vieria, J. E., Mitchell, R. W., Wylam, M. E., et al. (1999). Divergent differentiation paths in airway smooth muscle culture: induction of functionally contractile myocytes. American Physiology Society, 276, 197–206.
Hollrigel, A., Puz, S., Al-Dubai, H., Kim, J. U., Capetanaki, Y., & Weitzer, G. (2002). Amino-terminally truncated desmin rescues fusion of des-/- myoblasts but negatively affects cardioyogenesis and smooth muscle development. FEBS Letters, 523, 229–233.
van Eys, G. J., Niessen, P. M., & Rensen, S. S. (2007). Smoothelin in vascular smooth muscle cells. TCM, 17(1), 26–30.
Halayko, A. J., & Solway, J. (2001). Molecular mechanisms of phenotypic plasticity in smooth muscle cells. Journal of Applied Physiology, 90, 358–368.
Ma, X., Wang, Y., & Stephens, N. L. (1998). Serum deprivation induces a unique hypercontractile phenotype of cultured smooth muscle cells. AJP-Cell Physiology, 274, 1206–1214.
Woodrum, D. A., & Brophy, C. M. (2001). The paradox of smooth muscle physiology. Molecular and Cellular Endocrinology, 177, 135–143.
Owens, G. K., Kumar, M. S., & Wamhoff, B. R. (2004). Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiological Reviews, 84, 767–801.
Sinha, S., Wamhoff, B. R., Hoofnagle, M. H., Thomas, J., Neppi, R. L., Deering, T., et al. (2008). Assessment of contractility of purified smooth muscle cells derived from embryonic stem cells. Stem Cells, 24, 1678–1688.
Mayr, M., & Xu, Q. (2001). Smooth muscle cell apoptosis in arteriosclerosis. Experimental Gerontology, 36, 969–987.
Tukaj, C., Bohdanowicz, J., & Kubasik-Juraniec, J. (2004). The growth and differentiation of aortal smooth muscle cells with microtubule reorganisation—an in vitro study. Folia Morphologiica, 63(1), 51–57.
Liu, J. Y., Swartz, D. D., Peng, H. F., Gugino, S. F., Russell, J. A., & Andreadis, S. T. (2007). Functional tissue-engineered blood vessels from bone marrow progenitor cells. Circulation Research, 75, 618–628.
Wong, J. W., Velasco, A., Rajagopalan, P., & Pham, Q. (2003). Directed movement of vascular smooth muscle cells on gradient-compliant hydrogels. Langmuir, 19, 1908–1913.
Krenning, G., Moonen, J. R. A. J., van Luyn, M. J. A., & Harmsen, M. C. (2008). Vascular smooth muscle cells for use in vascular tissue engineering obtained by endothelial-to-mesenchymal transdifferentiation (EnMT) on collagen matrices. Biomaterials, 29, 3703–3711.
Campbell, J. H., Walker, P., Chue, W., Daly, C., Cong, H., Xiang, L., et al. (2004). Body cavities as bioreactors to grow arteries. International Congress Series, 1262, 118–121.
Hirst, S. L. (1996). Airway smooth muscle cell culture: application to studies of airway wall remodelling and phenotype plasticity in asthma. European Respiratory Journal, 9, 808–820.
James, A., & Carroll, N. (2000). Airway smooth muscle in health and disease; methods of measurement and relation to function. European Respiratory Journal, 15, 782–789.
Chakir, J., Pagé, N., Hamid, Q., Laviolette, M., Boulet, L. P., & Rouabhia, M. (2000). Bronchial mucosa produced by tissue engineering: a new tool to study cellular interactions in asthma. Journal of Allergy and Clinical Immunology, 107(1), 36–40.
Atala, A., Bauer, S., Soker, S., Yoo, J. J., & Retik, A. B. (2006). Tissue-engineered autologous bladders for patients needing cytoplasty. Lancet, 367, 1241–1246.
Jack, G. S., Zhang, R., Lee, M., Xu, Y., Wu, B. M., & Rodriguez, L. V. (2009). Urinary bladder smooth muscle engineered from adipose stem cells and a three dimensional synthetic composite. Biomaterials, 30, 3259–3270.
Sievert, K., Amend, B., & Stenzl, A. (2007). Tissue engineering for the lower urinary tract: a review of a state of the art approach. European Urology, 52, 1580–1589.
Baumert, H., Simon, P., Hekmati, M., Fromont, G., Levy, M., Balaton, A., et al. (2007). Development of a seeded scaffold in the great omentum: feasibility of an in vivo bioreactor for bladder tissue engineering. European Urology, 52, 884–892.
Kima, Y. M., Jeona, E. S., Kima, M. R., Jhob, S. K., Ryuc, S. W., & Kima, J. H. (2008). Angiotensin II-induced differentiation of adipose tissue-derived mesenchymal stem cells to smooth muscle-like cells. The International Journal of Biochemistry & Cell Biology, 40, 2482–2491.
Yang, P., Yin, S., Cui, L., Li, H., Wu, Y., Liu, W., et al. (2008). Experiment of adipose derived stem cells induced into smooth muscle cells. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 22(4), 481–486.
Ringe, J., Kaps, C., Burmester, G., & Sittinger, M. (2002). Stem cells for regenerative medicine: advances in the engineering of tissues and organs. Naturwissenschaften, 89, 338–351.
Moore, T. J. (2007). Stem cell Q and A—an introduction to stem cells and their role in scientific and medical research. Medical Technology SA, 21(1), 3–6.
Yanez, R., Lamana, L., Garcia-Castro, J., Colmenero, I., Ramirez, M., & Bueren, J. A. (2008). Adipose tissue-derived mesenchymal stem cells have in vivo immunosupressive properties applicable for the control of graft-versus-host disease. Stem Cells, 24, 2582–2591.
Mvula, B., Mathope, T., Moore, T., & Abrahamse, H. (2007). The effect of low level laser therapy on adipose derived stem cells. Lasers in Medical Science, 23(3), 277–282.
Mvula, B., Moore, T. J., Abrahamse, H. (2009). Effect of low-level laser irradiation and epidermal growth factor on adult human adipose-derived stem cells. Lasers in Medical Science. doi:10.1007/s10103-008-0636-1.
Dormorov, M. G., Kropp, B. P., Hurst, R. E., Cheng, E. Y., & Hsueh-Kung, L. (2007). Differentially expressed gene networks in cultured smooth muscle cells from normal and neuropathic bladder. Journal of Smooth Muscle Research, 43(2), 55–72.
Lin, H. K., Cowan, R., Moore, P., Zhang, Y., Yang, Q., Jr., Peterson, J. A., et al. (2004). Characterization of neuropathic bladder smooth muscle cells in culture. Journal of Urology, 171, 1348–1352.
Author disclosure statement
There is no conflict of interest for all authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Villiers, J.A., Houreld, N. & Abrahamse, H. Adipose Derived Stem Cells and Smooth Muscle Cells: Implications for Regenerative Medicine. Stem Cell Rev and Rep 5, 256–265 (2009). https://doi.org/10.1007/s12015-009-9084-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-009-9084-y